Skip to main content
NCBI home page
Quality in Health Care : QHC logoLink to Quality in Health Care : QHC
. 1995 Sep;4(3):218–226. doi: 10.1136/qshc.4.3.218

Managing menorrhagia.

A Coulter 1, A Long 1, J Kelland 1, S O'Meara 1, M Sculpher 1, F Song 1, T A Sheldon 1
PMCID: PMC1055321  PMID: 10153434

Full text

PDF
218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersch B., Milsom I., Rybo G. An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstet Gynecol Scand. 1988;67(7):645–648. doi: 10.3109/00016348809004279. [DOI] [PubMed] [Google Scholar]
  2. Bent A. E., Ostergard D. R. Endometrial ablation with the neodymium:Yag laser. Obstet Gynecol. 1990 Jun;75(6):923–925. [PubMed] [Google Scholar]
  3. Callender S. T., Warner G. T., Cope E. Treatment of menorrhagia with tranexamic acid. A double-blind trial. Br Med J. 1970 Oct 24;4(5729):214–216. doi: 10.1136/bmj.4.5729.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cameron I. T. Dysfunctional uterine bleeding. Baillieres Clin Obstet Gynaecol. 1989 Jun;3(2):315–327. doi: 10.1016/s0950-3552(89)80024-0. [DOI] [PubMed] [Google Scholar]
  5. Cameron I. T., Haining R., Lumsden M. A., Thomas V. R., Smith S. K. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol. 1990 Jul;76(1):85–88. [PubMed] [Google Scholar]
  6. Cameron I. T., Leask R., Kelly R. W., Baird D. T. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins. 1987 Jul;34(1):99–110. doi: 10.1016/0090-6980(87)90267-x. [DOI] [PubMed] [Google Scholar]
  7. Chamberlain G., Freeman R., Price F., Kennedy A., Green D., Eve L. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol. 1991 Jul;98(7):707–711. doi: 10.1111/j.1471-0528.1991.tb13460.x. [DOI] [PubMed] [Google Scholar]
  8. Chambers J. T., Chambers S. K. Endometrial sampling: When? Where? Why? With what? Clin Obstet Gynecol. 1992 Mar;35(1):28–39. doi: 10.1097/00003081-199203000-00007. [DOI] [PubMed] [Google Scholar]
  9. Chimbira T. H., Anderson A. B., Turnbull A. c. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol. 1980 Jul;87(7):603–609. doi: 10.1111/j.1471-0528.1980.tb05013.x. [DOI] [PubMed] [Google Scholar]
  10. Coulter A., Bradlow J., Agass M., Martin-Bates C., Tulloch A. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol. 1991 Aug;98(8):789–796. doi: 10.1111/j.1471-0528.1991.tb13484.x. [DOI] [PubMed] [Google Scholar]
  11. Coulter A., Klassen A., MacKenzie I. Z., McPherson K. Diagnostic dilatation and curettage: is it used appropriately? BMJ. 1993 Jan 23;306(6872):236–239. doi: 10.1136/bmj.306.6872.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coulter A., McPherson K., Vessey M. Do British women undergo too many or too few hysterectomies? Soc Sci Med. 1988;27(9):987–994. doi: 10.1016/0277-9536(88)90289-4. [DOI] [PubMed] [Google Scholar]
  13. Crow J., Gordon H., Hudson E. An assessment of the Mi-Mark endoemtrial sampling technique. J Clin Pathol. 1980 Jan;33(1):72–80. doi: 10.1136/jcp.33.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Davies A. J., Anderson A. B., Turnbull A. C. Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstet Gynecol. 1981 Jan;57(1):74–78. [PubMed] [Google Scholar]
  15. Deeny M., Davis J. A. Assessment of menstrual blood loss in women referred for endometrial ablation. Eur J Obstet Gynecol Reprod Biol. 1994 Dec;57(3):179–180. doi: 10.1016/0028-2243(94)90297-6. [DOI] [PubMed] [Google Scholar]
  16. Dicker R. C., Greenspan J. R., Strauss L. T., Cowart M. R., Scally M. J., Peterson H. B., DeStefano F., Rubin G. L., Ory H. W. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization. Am J Obstet Gynecol. 1982 Dec 1;144(7):841–848. doi: 10.1016/0002-9378(82)90362-3. [DOI] [PubMed] [Google Scholar]
  17. Dockeray C. J., Sheppard B. L., Bonnar J. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. Br J Obstet Gynaecol. 1989 Jul;96(7):840–844. doi: 10.1111/j.1471-0528.1989.tb03325.x. [DOI] [PubMed] [Google Scholar]
  18. Dwyer N., Hutton J., Stirrat G. M. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. Br J Obstet Gynaecol. 1993 Mar;100(3):237–243. doi: 10.1111/j.1471-0528.1993.tb15237.x. [DOI] [PubMed] [Google Scholar]
  19. Eddowes H. A., Read M. D., Codling B. W. Pipelle: a more acceptable technique for outpatient endometrial biopsy. Br J Obstet Gynaecol. 1990 Oct;97(10):961–962. doi: 10.1111/j.1471-0528.1990.tb02458.x. [DOI] [PubMed] [Google Scholar]
  20. Ferenczy A., Gelfand M. M. Outpatient endometrial sampling with Endocyte: comparative study of its effectiveness with endometrial biopsy. Obstet Gynecol. 1984 Mar;63(3):295–302. [PubMed] [Google Scholar]
  21. Fraser I. S. Hysteroscopy and laparoscopy in women with menorrhagia. Am J Obstet Gynecol. 1990 May;162(5):1264–1269. doi: 10.1016/0002-9378(90)90032-3. [DOI] [PubMed] [Google Scholar]
  22. Fraser I. S., McCarron G., Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol. 1984 Aug 1;149(7):788–793. doi: 10.1016/0002-9378(84)90123-6. [DOI] [PubMed] [Google Scholar]
  23. Fraser I. S., McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. 1991 Feb;31(1):66–70. doi: 10.1111/j.1479-828x.1991.tb02769.x. [DOI] [PubMed] [Google Scholar]
  24. Fraser I. S., Pearse C., Shearman R. P., Elliott P. M., McIlveen J., Markham R. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol. 1981 Nov;58(5):543–551. [PubMed] [Google Scholar]
  25. Gallegost A. J., Aznar R., Merino G., Guizer E. Intrauterine devices and menstrual blood loss. A comparative study of eight devices during the first six months of use. Contraception. 1978 Feb;17(2):153–161. doi: 10.1016/0010-7824(78)90071-9. [DOI] [PubMed] [Google Scholar]
  26. Gannon M. J., Holt E. M., Fairbank J., Fitzgerald M., Milne M. A., Crystal A. M., Greenhalf J. O. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ. 1991 Nov 30;303(6814):1362–1364. doi: 10.1136/bmj.303.6814.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gillespie A., Nichols A. The value of hysteroscopy. Aust N Z J Obstet Gynaecol. 1994 Feb;34(1):85–87. doi: 10.1111/j.1479-828x.1994.tb01045.x. [DOI] [PubMed] [Google Scholar]
  28. Gimpelson R. J., Rappold H. O. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol. 1988 Mar;158(3 Pt 1):489–492. doi: 10.1016/0002-9378(88)90011-7. [DOI] [PubMed] [Google Scholar]
  29. Goldberg G. L., Tsalacopoulos G., Davey D. A. A comparison of endometrial sampling with the Accurette and Vabra aspirator and uterine curettage. S Afr Med J. 1982 Jan 23;61(4):114–116. [PubMed] [Google Scholar]
  30. Goldfarb H. A. A review of 35 endometrial ablations using the Nd:YAG laser for recurrent menometrorrhagia. Obstet Gynecol. 1990 Nov;76(5 Pt 1):833–835. doi: 10.1097/00006250-199011000-00022. [DOI] [PubMed] [Google Scholar]
  31. Goldrath M. H., Sherman A. I. Office hysteroscopy and suction curettage: can we eliminate the hospital diagnostic dilatation and curettage? Am J Obstet Gynecol. 1985 May 15;152(2):220–229. doi: 10.1016/s0002-9378(85)80026-0. [DOI] [PubMed] [Google Scholar]
  32. Gregg R. H. The praxeology of the office dilatation and curettage. Am J Obstet Gynecol. 1981 May 15;140(2):179–185. doi: 10.1016/0002-9378(81)90106-x. [DOI] [PubMed] [Google Scholar]
  33. Guillebaud J., Anderson A. B., Turnbull A. C. Reduction of mefenamic acid of increased menstrual blood loss associated with intrauterine contraception. Br J Obstet Gynaecol. 1978 Jan;85(1):53–62. doi: 10.1111/j.1471-0528.1978.tb15826.x. [DOI] [PubMed] [Google Scholar]
  34. Haack-Sørensen P. E., Starklint H., Aronsen A., Hansen M. K., Kristoffersen K. Diagnostic Vabra (aspiration) curettage. An evaluation of the diagnostic certainty, efficacy, acceptability, indication and socio-medical importance. Dan Med Bull. 1979 Feb;26(1):1–6. [PubMed] [Google Scholar]
  35. Hall P., Maclachlan N., Thorn N., Nudd M. W., Taylor C. G., Garrioch D. B. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Br J Obstet Gynaecol. 1987 Jun;94(6):554–558. doi: 10.1111/j.1471-0528.1987.tb03150.x. [DOI] [PubMed] [Google Scholar]
  36. Hallberg L., Högdahl A. M., Nilsson L., Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45(3):320–351. doi: 10.3109/00016346609158455. [DOI] [PubMed] [Google Scholar]
  37. Hammond R. H., Oppenheimer L. W., Saunders P. G. Diagnostic role of dilatation and curettage in the management of abnormal premenopausal bleeding. Br J Obstet Gynaecol. 1989 Apr;96(4):496–497. doi: 10.1111/j.1471-0528.1989.tb02433.x. [DOI] [PubMed] [Google Scholar]
  38. Hansen P. K., Junge J., Roed H., Fischer-Rasmussen W., Højgaard K. Endoscann cell sampling for cytological assessment of endometrial pathology. Acta Obstet Gynecol Scand. 1986;65(5):397–399. doi: 10.3109/00016348609157371. [DOI] [PubMed] [Google Scholar]
  39. Harrison R. F., Cambell S. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia. Lancet. 1976 Aug 7;2(7980):283–285. doi: 10.1016/s0140-6736(76)90733-9. [DOI] [PubMed] [Google Scholar]
  40. Haynes P. J., Hodgson H., Anderson A. B., Turnbull A. C. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol. 1977 Oct;84(10):763–768. doi: 10.1111/j.1471-0528.1977.tb12490.x. [DOI] [PubMed] [Google Scholar]
  41. Henig I., Chan P., Tredway D. R., Maw G. M., Gullett A. J., Cheatwood M. Evaluation of the Pipelle curette for endometrial biopsy. J Reprod Med. 1989 Oct;34(10):786–789. [PubMed] [Google Scholar]
  42. Higham J. M., Shaw R. W. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol. 1993 Nov;169(5):1134–1139. doi: 10.1016/0002-9378(93)90269-o. [DOI] [PubMed] [Google Scholar]
  43. Higham J. M., Shaw R. W. Risk-benefit assessment of drugs used for the treatment of menstrual disorders. Drug Saf. 1991 May-Jun;6(3):183–191. doi: 10.2165/00002018-199106030-00004. [DOI] [PubMed] [Google Scholar]
  44. Hofmeister F. J. Endometrial biopsy: another look. Am J Obstet Gynecol. 1974 Mar 15;118(6):773–777. doi: 10.1016/0002-9378(74)90486-4. [DOI] [PubMed] [Google Scholar]
  45. Iossa A., Cianferoni L., Ciatto S., Cecchini S., Campatelli C., Lo Stumbo F. Hysteroscopy and endometrial cancer diagnosis: a review of 2007 consecutive examinations in self-referred patients. Tumori. 1991 Dec 31;77(6):479–483. doi: 10.1177/030089169107700606. [DOI] [PubMed] [Google Scholar]
  46. Irwin K. L., Lee N. C., Peterson H. B., Rubin G. L., Wingo P. A., Mandel M. G. Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol. 1988 Jun;127(6):1192–1201. doi: 10.1093/oxfordjournals.aje.a114912. [DOI] [PubMed] [Google Scholar]
  47. Itzkowic D. J., Laverty C. R. Office hysteroscopy and curettage--a safe diagnostic procedure. Aust N Z J Obstet Gynaecol. 1990 May;30(2):150–153. doi: 10.1111/j.1479-828x.1990.tb03250.x. [DOI] [PubMed] [Google Scholar]
  48. Jacobs S. A., Blumenthal N. J. Endometrial resection follow up: late onset of pain and the effect of depot medroxyprogesterone acetate. Br J Obstet Gynaecol. 1994 Jul;101(7):605–609. doi: 10.1111/j.1471-0528.1994.tb13651.x. [DOI] [PubMed] [Google Scholar]
  49. Kaunitz A. M., Masciello A., Ostrowski M., Rovira E. Z. Comparison of endometrial biopsy with the endometrial Pipelle and Vabra aspirator. J Reprod Med. 1988 May;33(5):427–431. [PubMed] [Google Scholar]
  50. Koonings P. P., Grimes D. A. Endometrial sampling techniques for the office. Am Fam Physician. 1989 Oct;40(4):207–210. [PubMed] [Google Scholar]
  51. Koonings P. P., Moyer D. L., Grimes D. A. A randomized clinical trial comparing Pipelle and Tis-u-trap for endometrial biopsy. Obstet Gynecol. 1990 Feb;75(2):293–295. doi: 10.1016/0020-7292(90)90378-x. [DOI] [PubMed] [Google Scholar]
  52. Kovac S. R., Christie S. J., Bindbeutel G. A. Abdominal versus vaginal hysterectomy: a statistical model for determining physician decision making and patient outcome. Med Decis Making. 1991 Jan-Mar;11(1):19–28. doi: 10.1177/0272989X9101100103. [DOI] [PubMed] [Google Scholar]
  53. LaPolla J. P., Nicosia S., McCurdy C., Songster C., Ruffolo E., Roberts W. S., Hoffman M. S., Fiorica J. V., Cavanagh D. Experience with the EndoPap device for the cytologic detection of uterine cancer and its precursors: a comparison of the EndoPap with fractional curettage or hysterectomy. Am J Obstet Gynecol. 1990 Sep;163(3):1055–1060. doi: 10.1016/0002-9378(90)91125-v. [DOI] [PubMed] [Google Scholar]
  54. Lewis B. V. Diagnostic dilatation and curettage in young women. BMJ. 1993 Jan 23;306(6872):225–226. doi: 10.1136/bmj.306.6872.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lewis B. V. Hysteroscopy for the investigation of abnormal uterine bleeding. Br J Obstet Gynaecol. 1990 Apr;97(4):283–284. doi: 10.1111/j.1471-0528.1990.tb01803.x. [DOI] [PubMed] [Google Scholar]
  56. Loffer F. D. Hysteroscopic endometrial ablation with the Nd:Yag laser using a nontouch technique. Obstet Gynecol. 1987 Apr;69(4):679–682. [PubMed] [Google Scholar]
  57. Loffer F. D. Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstet Gynecol. 1989 Jan;73(1):16–20. [PubMed] [Google Scholar]
  58. Lutz M. H., Underwood P. B., Jr, kreutner A., Mitchell K. S. Vacuum aspiration: an efficient outpatient screening technic for endometrial disease. South Med J. 1977 Apr;70(4):393–395. [PubMed] [Google Scholar]
  59. Löfgren O., Alm P., Ionescu A., Skjerris J. Uterine microcurettage with combined endometrial histopathology and cytology. An alternative to conventional curettage. Acta Obstet Gynecol Scand. 1988;67(5):401–403. doi: 10.3109/00016348809004248. [DOI] [PubMed] [Google Scholar]
  60. MacKenzie I. Z., Bibby J. G. Critical assessment of dilatation and curettage in 1029 women. Lancet. 1978 Sep 9;2(8089):566–568. doi: 10.1016/s0140-6736(78)92895-7. [DOI] [PubMed] [Google Scholar]
  61. MacKenzie I. Z. Routine outpatient diagnostic uterine curettage using a flexible plastic aspiration curette. Br J Obstet Gynaecol. 1985 Dec;92(12):1291–1296. doi: 10.1111/j.1471-0528.1985.tb04878.x. [DOI] [PubMed] [Google Scholar]
  62. Mencaglia L., Perino A., Hamou J. Hysteroscopy in perimenopausal and postmenopausal women with abnormal uterine bleeding. J Reprod Med. 1987 Aug;32(8):577–582. [PubMed] [Google Scholar]
  63. Milsom I., Andersson K., Andersch B., Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol. 1991 Mar;164(3):879–883. doi: 10.1016/s0002-9378(11)90533-x. [DOI] [PubMed] [Google Scholar]
  64. Mittendorf R., Aronson M. P., Berry R. E., Williams M. A., Kupelnick B., Klickstein A., Herbst A. L., Chalmers T. C. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol. 1993 Nov;169(5):1119–1124. doi: 10.1016/0002-9378(93)90266-l. [DOI] [PubMed] [Google Scholar]
  65. Mäkäräinen L., Ylikorkala O. Ibuprofen prevents IUCD-induced increases in menstrual blood loss. Br J Obstet Gynaecol. 1986 Mar;93(3):285–288. doi: 10.1111/j.1471-0528.1986.tb07910.x. [DOI] [PubMed] [Google Scholar]
  66. Nilsson C. G. Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device. Contraception. 1977 Apr;15(4):379–387. doi: 10.1016/0010-7824(77)90001-4. [DOI] [PubMed] [Google Scholar]
  67. Pinion S. B., Parkin D. E., Abramovich D. R., Naji A., Alexander D. A., Russell I. T., Kitchener H. C. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ. 1994 Oct 15;309(6960):979–983. doi: 10.1136/bmj.309.6960.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Preston J. T., Cameron I. T., Adams E. J., Smith S. K. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol. 1995 May;102(5):401–406. doi: 10.1111/j.1471-0528.1995.tb11293.x. [DOI] [PubMed] [Google Scholar]
  69. Problems with endometrial resection. Lancet. 1991 Jun 15;337(8755):1473–1474. [PubMed] [Google Scholar]
  70. Pyper R. J., Haeri A. D. A review of 80 endometrial resections for menorrhagia. Br J Obstet Gynaecol. 1991 Oct;98(10):1049–1054. doi: 10.1111/j.1471-0528.1991.tb15345.x. [DOI] [PubMed] [Google Scholar]
  71. Rees M. C. Role of menstrual blood loss measurements in management of complaints of excessive menstrual bleeding. Br J Obstet Gynaecol. 1991 Mar;98(3):327–328. doi: 10.1111/j.1471-0528.1991.tb13406.x. [DOI] [PubMed] [Google Scholar]
  72. Rybo G., Nilsson S., Sikström B., Nygren K. G. Naproxen in menorrhagia. Lancet. 1981 Mar 14;1(8220 Pt 1):608–609. doi: 10.1016/s0140-6736(81)92051-1. [DOI] [PubMed] [Google Scholar]
  73. Sandberg S. I., Barnes B. A., Weinstein M. C., Braun P. Elective hysterectomy. Benefits, risks, and costs. Med Care. 1985 Sep;23(9):1067–1085. [PubMed] [Google Scholar]
  74. Sculpher M. J., Bryan S., Dwyer N., Hutton J., Stirrat G. M. An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol. 1993 Mar;100(3):244–252. doi: 10.1111/j.1471-0528.1993.tb15238.x. [DOI] [PubMed] [Google Scholar]
  75. Shapiro M., Muñoz A., Tager I. B., Schoenbaum S. C., Polk B. F. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med. 1982 Dec 30;307(27):1661–1666. doi: 10.1056/NEJM198212303072701. [DOI] [PubMed] [Google Scholar]
  76. Smith J. J., Schulman H. Current dilatation and curettage practice: a need for revision. Obstet Gynecol. 1985 Apr;65(4):516–518. [PubMed] [Google Scholar]
  77. Speroff T., Dawson N. V., Speroff L., Haber R. J. A risk-benefit analysis of elective bilateral oophorectomy: effect of changes in compliance with estrogen therapy on outcome. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):165–174. doi: 10.1016/0002-9378(91)90649-c. [DOI] [PubMed] [Google Scholar]
  78. Stovall T. G., Ling F. W., Morgan P. L. A prospective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette. Am J Obstet Gynecol. 1991 Nov;165(5 Pt 1):1287–1290. doi: 10.1016/0002-9378(91)90351-q. [DOI] [PubMed] [Google Scholar]
  79. Stovall T. G., Solomon S. K., Ling F. W. Endometrial sampling prior to hysterectomy. Obstet Gynecol. 1989 Mar;73(3 Pt 1):405–409. [PubMed] [Google Scholar]
  80. Suarez R. A., Grimes D. A., Majmudar B., Benigno B. B. Diagnostic endometrial aspiration with the Karman cannula. J Reprod Med. 1983 Jan;28(1):41–44. [PubMed] [Google Scholar]
  81. Valle R. F. Hysteroscopic evaluation of patients with abnormal uterine bleeding. Surg Gynecol Obstet. 1981 Oct;153(4):521–526. [PubMed] [Google Scholar]
  82. Vargyas J. M., Campeau J. D., Mishell D. R., Jr Treatment of menorrhagia with meclofenamate sodium. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):944–950. doi: 10.1016/s0002-9378(87)80093-5. [DOI] [PubMed] [Google Scholar]
  83. Vermylen J., Verhaegen-Declercq M. L., Verstraete M., Fierens F. A double blind study of the effect of tranexamic acid in essential menorrhagia. Thromb Diath Haemorrh. 1968 Dec 31;20(3):583–587. [PubMed] [Google Scholar]
  84. Vessey M. P., Clarke J. A., MacKenzie I. Z. Dilatation and curettage in young women. Health Bull (Edinb) 1979 Mar;37(2):59–62. [PubMed] [Google Scholar]
  85. WORD B., GRAVLEE L. C., WIDEMAN G. L. The fallacy of simple uterine curettage. Obstet Gynecol. 1958 Dec;12(6):642–648. [PubMed] [Google Scholar]
  86. Webb M. J., Gaffey T. A. Outpatient diagnostic aspiration curettage. Obstet Gynecol. 1976 Feb;47(2):239–242. [PubMed] [Google Scholar]
  87. Ylikorkala O., Pekonen F. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia. Obstet Gynecol. 1986 Jul;68(1):10–12. [PubMed] [Google Scholar]
  88. Ylikorkala O., Viinikka L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Br J Obstet Gynaecol. 1983 Jan;90(1):78–83. doi: 10.1111/j.1471-0528.1983.tb06751.x. [DOI] [PubMed] [Google Scholar]
  89. de Jong P., Doel F., Falconer A. Outpatient diagnostic hysteroscopy. Br J Obstet Gynaecol. 1990 Apr;97(4):299–303. doi: 10.1111/j.1471-0528.1990.tb01805.x. [DOI] [PubMed] [Google Scholar]
  90. van Eijkeren M. A., Christiaens G. C., Geuze H. J., Haspels A. A., Sixma J. J. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. Am J Obstet Gynecol. 1992 May;166(5):1419–1428. doi: 10.1016/0002-9378(92)91614-g. [DOI] [PubMed] [Google Scholar]

Articles from Quality in Health Care are provided here courtesy of BMJ Publishing Group

RESOURCES